Search Share Prices
GSK Share Price - GlaxoSmithKline’s (GSK) Hold Rating Reaffirmed at Deutsche Bank Aktiengesellschaft
GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “hold” rating reissued by equities researchers at Deutsche Bank Aktiengesellschaft in a research report issued on Wednesday, MarketBeat Ratings ...
GlaxoSmithKline plc (LON:GSK) Given Consensus Rating of “Hold” by Brokerages
Shares of GlaxoSmithKline plc (LON:GSK – Get Rating) have been given an average rating of “Hold” by the fourteen research firms that are currently covering the firm, MarketBeat Ratings reports. Five ...
GlaxoSmithKline (LON:GSK) PT Set at GBX 2,100 by Jefferies Financial Group
GlaxoSmithKline (LON:GSK – Get Rating) has been given a GBX 2,100 ($27.32) price target by stock analysts at Jefferies Financial Group in a report issued on Tuesday, Borsen Zeitung reports. Jefferies ...
JPMorgan Chase & Co. Analysts Give GlaxoSmithKline (LON:GSK) a GBX 1,740 Price Target
GlaxoSmithKline (LON:GSK – Get Rating) has been assigned a GBX 1,740 ($22.64) target price by stock analysts at JPMorgan Chase & Co. in a note issued to investors on Tuesday, Borsen Zeitung reports.
How Immutep Treats Head & Neck Cancer
ShareCafe spoke with Marc Voigt, CEO of local biotech Immutep, about the progress his company is making specifically in the area of head and neck cancer treatments.